Results 51 to 60 of about 24,186,788 (290)

Stratified analysis of individuals with co-infecttion Syphilis/HIV-1 subtypes B and non-B.

, 2016
Stratified analysis of individuals with co-infecttion Syphilis/HIV-1 subtypes B and non-B.
Ana Maria Salustiano Cavalcanti (2806885), Kledoaldo Lima (2806882), Élcio de Souza Leal (2806888), Daniela Medeiros Salustiano (2806879), Sirleide Pereira da Silva (2806876), Luzidalva Barbosa de Medeiros (2806891), Heloísa Ramos Lacerda (2806873)   +6 more
core   +1 more source

Reservoir differences across HIV-1 subtypes: a systematic review to guide cure research

Frontiers in Immunology
IntroductionDespite effective antiretroviral therapy, HIV-1 persists as a viral reservoir and remains a major barrier to a durable cure. Reservoir size and dynamics are central determinants of the success of cure strategies.
Myrthe S. Willemsen, Myrthe S. Willemsen, Anniek A. N. Tanja, Sody Munsaka, Damalie Nakanjako, Damalie Nakanjako, Thumbi Ndung’u, Thumbi Ndung’u, Thumbi Ndung’u, Thumbi Ndung’u, Maria A. Papathanasopoulos, Kevin Jenniskens, Kevin Jenniskens, Giulia Sinatti, Giulia Sinatti, Jori Symons, Annemarie M. J. Wensing, Monique Nijhuis, Monique Nijhuis, Ganna Rozhnova, Ganna Rozhnova, Ganna Rozhnova, Ganna Rozhnova   +22 more
doaj   +1 more source

Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience

Journal of Global Antimicrobial Resistance, 2020
Objectives: Transmitted drug resistance (TDR) and HIV-1 genetic diversity may affect treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and estimate the prevalence of drug resistance among antiretroviral therapy ...
Laura Mazzuti, Taulant Melengu, Francesca Falasca, Marianna Calabretto, Eleonora Cella, Massimo Ciccozzi, Ivano Mezzaroma, Giancarlo Iaiani, Martina Spaziante, Gabriella d’Ettorre, Caterina Fimiani, Vincenzo Vullo, Guido Antonelli, Ombretta Turriziani   +13 more
doaj   +1 more source

Stratified analysis of individuals with co-infecttion HBV/HIV-1 subtypes B and non-B.

, 2016
Stratified analysis of individuals with co-infecttion HBV/HIV-1 subtypes B and non-B.
Ana Maria Salustiano Cavalcanti (2806885), Kledoaldo Lima (2806882), Élcio de Souza Leal (2806888), Daniela Medeiros Salustiano (2806879), Sirleide Pereira da Silva (2806876), Luzidalva Barbosa de Medeiros (2806891), Heloísa Ramos Lacerda (2806873)   +6 more
core   +1 more source

Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy

, 2022
Objectives and design: Using pol sequences obtained for routine resistance testing, we characterised the molecular patterns of HIV-1 transmission and factors associated with being part of a transmission cluster among individuals who in 2008-2014 ...
Ripamonti, Diego, Giulia Berno, Silvia Nozza, Benedetto Maurizio Celesia, Foca' Emanuele, Lucia Taramasso, Massimiliano Fabbiani, Abbate, Isabella, Vanni Borghi, Eugenia Quiros-Roldan, Gabriella d'Ettorre, Lavinia Fabeni, Giacomelli, Andrea, Nicola Squillace, Tambussi, Giuseppe, Andrea Gori, Bandera, Alessandra, Isabella Abbate, Antonio Di Biagio, Fabeni, Lavinia, Andrea Antinori, Borghi, Vanni, Taramasso, Lucia, Stefano Rusconi, Giordano Madeddu, Bozzi, Giorgio, Capobianchi, Maria Rosaria, Mussini, Cristina, Fabbiani, Massimiliano, Alessandra Bandera, Berno, Giulia, Celesia, Benedetto Maurizio, Emanuele Focà, Antinori, Andrea, Di Biagio, Antonio, Nozza, Silvia, Antonio Muscatello, Diego Ripamonti, d'Ettorre, Gabriella, Maria Rosaria Capobianchi, Rusconi, Stefano, Giuseppe Tambussi, Muscatello, Antonio, Focà, Emanuele, Squillace, Nicola, Pinnetti, Carmela, Cristina Mussini, Andrea Giacomelli, Carmela Pinnetti, Madeddu, Giordano, Gori, Andrea, Giorgio Bozzi, Giacomelli A, Bandera A, Abbate I., Squillace N., Borghi V, Muscatello A., Madeddu G, Gori A., Nozza S., Celesia B. M., Bozzi G., Fabeni L, Fabbiani M, Ripamonti D., Antinori A, Taramasso L., Di Biagio A, the INACTION study group, Madeddu G., Mussini C., Bozzi G, Antinori A., Ripamonti D, Fabeni L., Rusconi S, Abbate I, Borghi V., Giacomelli A., Muscatello A, INACTION study group., Taramasso L, Bandera A., Focà E, Berno G, Squillace N, Foca E., NOZZA S, Rusconi S., Celesia BM, Fabbiani M., Tambussi G, Pinnetti C, Capobianchi MR, Pinnetti C., Gori A, Berno G., Tambussi G., D'Ettorre G., Capobianchi M. R., d'Ettorre G, Di Biagio A., Mussini C   +103 more
core   +2 more sources

Impact of HIV-1 subtypes on gross deletion in the nef gene after Korean Red Ginseng treatment

Journal of Ginseng Research, 2022
Background: The number of primary human immunodeficiency virus (HIV)-1 non-B subtype infections (non-B) and that of reports regarding the differences in the pathogenesis of subtype B and non-B infections are increasing.
Young-Keol Cho, Jung-Eun Kim, Jinny Lee
doaj   +1 more source

Translating Molecular Subtypes into Cost-Effective Radiogenomic Biomarkers for Prognosis of Colorectal Cancer

Diagnostics
Background: Colorectal cancer (CRC) is currently the third most common cancer worldwide, with high heterogeneity and poor prognosis. Gene expression-based molecular subtypes can effectively dissect tumor heterogeneity, but their clinical translation ...
Baowen Gai, Xin Duan, Chenghang Li, Chuling Hu, Minyi Lv, Jiaxin Lei, Runxian Wang, Feng Gao, Du Cai   +8 more
doaj   +1 more source

Demographic and laboratory characteristic among HIV-1 subtypes B and non-B.

, 2016
Demographic and laboratory characteristic among HIV-1 subtypes B and non-B.
Ana Maria Salustiano Cavalcanti (2806885), Kledoaldo Lima (2806882), Élcio de Souza Leal (2806888), Daniela Medeiros Salustiano (2806879), Sirleide Pereira da Silva (2806876), Luzidalva Barbosa de Medeiros (2806891), Heloísa Ramos Lacerda (2806873)   +6 more
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source